Civil Money Penalties Relating to the ClinicalTrialsgov Data Bank: Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 14, 2020
November 5, 2024
0e9dc583-3ef6-4205-9302-de301840b935
Related Documents
Current Good Manufacturing Practice Requirements for Combination Products: Guidance for Industry and FDA Staff
Guidance DocumentJanuary 11, 2017Center for Drug Evaluation and Research
Evaluation of Sex Differences in Clinical Investigations: Guidance for Industry
Guidance DocumentJanuary 20, 2025Office of the Commissioner
Adverse Event Reporting to IRBs — Improving Human Subject Protection: Guidance for Clinical Investigators, Sponsors, and IRBs
Guidance DocumentJanuary 14, 2009Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.